Respiratory Tract Infections Global Clinical Research Report : Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Respiratory Tract Infections Global Clinical Trials Review, H1, 2018, a clinical trial report by GlobalData gives an overview of clinical trials scenario for respiratory tract infections. It contains information regarding trial numbers, average enrolment in top countries, region-wise and country-wise (G7 & E7) trials coverage, trial phase, status and prominent drugs for in progress trials. It also contains details of unaccomplished trials and trial enrolment trend seen in last five years. Thus, giving a better understanding to the stakeholders regarding trial progresses, market opportunities and market growth. Respiratory tract infections are infectious diseases caused in the respiratory tract. It is one of the most prevalent and most variable infections occurring. These infections are generally classified as Upper respiratory tract and lower respiratory tract infections. Upper respiratory tract infections (URTI) are less severe. Rhinitis, sinusitis, tonsillitis, laryngitis, common cold, etc. are examples of these infection. Lower respiratory infections are more serious conditions like pneumonia and bronchitis. Respiratory tract infections are reason for more than half of the total registered antibiotic prescriptions. The fact that respiratory tract infections occur so commonly -especially the upper respiratory tract infection, that it has created a problem for the effective treatment of the same. In many cases antibiotics are prescribed even if the symptoms are mild. Many patients take antibiotics that are self-administered. This significantly increases the drug resistance of the microorganism causing the infection. Also, experts believe that while most of the respiratory tract infections are cured through antimicrobial drugs; there are a few infections that are caused by respiratory virus instead of bacteria and in such cases antibiotics are not to be prescribed. If such cases not examined properly, can lead to antibiotic abuse. Respiratory tract infections as a whole, contains a huge portfolio of clinical diseases. There are many factors responsible for the variation in medical cases. These are: patient demographics, epidemiology, local surrounding factors, and access as well as amount of exposure to antimicrobial therapy. Hence, there is a worldwide need for new and effective treatments of such infections. The global clinical trials market is on rise and with increasing global demand for effective drugs and therapies, the growth is anticipated to continue for the next decade. The main drivers of this potential growth will be technological advancements, globalization, diversity in medical profiles, population, economic developments and favourable business regulations and policies. Apart from this there is increase in the funding and investments from private entities. A market shift might be the future, as companies are focusing on the emerging countries for their potential markets and business expansions. Also, the new- generation technologies are now helping the small and mid- size firms and research institutes to have access to technology, data and research platforms, that were earlier available to only the big players. Companies involved in the clinical trials for respiratory tract infections and covered in the report are: GlaxoSmithKline Plc, Novartis AG, Pfizer Inc, Sanofi, Reckitt Benckiser Group Plc, Venus Remedies Ltd, Abbott Laboratories, NPF Materia Medica Holding, Syneos Health Inc, Sun Pharmaceutical Industries Ltd. To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/respiratory-tract-infections/154916-91.html Related Reports:- https://www.kenresearch.com/healthcare/pharmaceuticals/lower-respiratory-tract-infections-global-clinical/142654-91.html https://www.kenresearch.com/healthcare/pharmaceuticals/acute-upper-respiratory-tract-infections-global/100097-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com +91-9015378249 Post Views: 8 Tags: Global Respiratory Tract Infection Treatment Causes, Global Respiratory Tract Infection Treatment Cure, Global Respiratory Tract Infection Treatment Diagnosis, Global Respiratory Tract Infection Treatment Market Major Players, Global Respiratory Tract Infection Treatment Market Research Report, Global Respiratory Tract Infection Treatment Prevention, Global Respiratory Tract Infection Treatment Symptoms, Respiratory Tract Infection Treatment Industry Research Report, Respiratory Tract Infection Treatment Market analysis, Respiratory Tract Infection Treatment Market Forecast, Respiratory Tract Infection Treatment Market Growth, Respiratory Tract Infection Treatment Market Size